Inhibition of β-catenin-mediated transactivation by flavanone in AGS gastric cancer cells
- 1 June 2005
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 331 (4), 1222-1228
- https://doi.org/10.1016/j.bbrc.2005.03.242
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- β-catenin-mediated signaling: a molecular target for early chemopreventive interventionMutation Research, 2004
- Inhibition of β-catenin/Tcf activity by white tea, green tea, and epigallocatechin-3-gallate (EGCG): minor contribution of H2O2 at physiologically relevant EGCG concentrationsBiochemical and Biophysical Research Communications, 2002
- Sophoranone, extracted from a traditional Chinese medicine Shan Dou Gen, induces apoptosis in human leukemia U937 cells via formation of reactive oxygen species and opening of mitochondrial permeability transition poresInternational Journal of Cancer, 2002
- Frequent β-catenin aberration in human hepatocellular carcinomaHepatology Research, 2001
- The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate β-catenin/TCF-4 signalingOncogene, 2001
- Tyrosine phosphorylation and cadherin/catenin functionBioEssays, 1997
- Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APCScience, 1997
- Dietary Flavonoid and Cancer Prevention: Evidence and Potential MechanismCritical Reviews™ in Oncogenesis, 1997
- Polyphenols as cancer chemopreventive agentsJournal of Cellular Biochemistry, 1995
- Somatic mutation of the APC gene in gastric cancer: frequent mutations in very well differentiated adenocarcinoma and signet-ring cell carcinomaHuman Molecular Genetics, 1992